Corona Remedies IPO is to open on December 8, 2025. It is a Mainboard IPO that will raise ₹655.37 crores. The Corona Remedies IPO price band is fixed at ₹1008 to ₹1062 with a market lot of 14 Shares.
Corona Remedies IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 15 Dec | ₹340 |  | 32.01% |
| 13 Dec | ₹330 | | 31.07% |
| 12 Dec | ₹291 |  | 27.40% |
| 12 Dec | ₹291 | | 27.40% |
| 11 Dec | ₹305 | | 28.71% |
| 10 Dec | ₹270 | | 25.42% |
| 9 Dec | ₹262 | | 24.67% |
| 8 Dec | ₹290 | | 27.31% |
| 6 Dec | ₹365 | | 34.37% |
| 5 Dec | ₹365 | | 34.37% |
| 4 Dec | ₹307 | | 28.91% |
| 3 Dec | ₹- | – | -% |
| 2 Dec | ₹- | – | -% |
Corona Remedies IPO Details
| IPO Open Date | December 8, 2025 |
| IPO Close Date | December 10, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹1008 to ₹1062 Per Share |
| Issue Size | Approx ₹655.37 Crores |
| Offer for Sale: | Approx 61,71,101 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Corona Remedies IPO Dates
| IPO Open Date: | December 8, 2025 |
| IPO Close Date: | December 10, 2025 |
| Basis of Allotment: | December 11, 2025 |
| Refunds: | December 12, 2025 |
| Credit to Demat Account: | December 12, 2025 |
| IPO Listing Date: | December 15, 2025 |
| IPO Bidding Cut-off Time: | December 10, 2025 – 5 PM |
Business Overview
Founded in August 2004, Corona Remedies Limited is one of the leading pharmaceutical companies that is involved in manufacturing and selling products for women’s health, heart care, pain relief, urology, and other treatments. As per the report, among 30 others, Corona Remedies is the 2nd largest company in the Indian Pharmaceutical Market (“IPM”). Moreover, the company comprises a total of 88 R&D employees as of December 31, 2024.
The company offers 67 brands across various therapeutic areas, including women’s healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals (including vitamins/minerals/nutrition, gastrointestinal, and respiratory) as of December 2024. The company offers a pan-India presence with 2,598 medical representatives in 22 states. It comprises 2 manufacturing facilities located in the state of Gujarat.
Corona Remedies IPO GMP aka Grey Market Premium FAQs:
What is Corona Remedies IPO GMP Today?
What is Corona Remedies IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Corona Remedies IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
10 Responses
Hello, corona remadies ipo alloted 1 lot , is it advisable to hold or to sell ??? Pls give brief details
Hi Abhiraj,
You can hold 50% and sell 50% on the listing day. If you want to go for long term, its always good to have this stock in your portfolio.
I was allotted 14 shares in Corona Remidies IPO shall I hold or sell it, please advise me.
Hi Amarnath,
Hold 50% of stock and sell 50% of stock.
[email protected]
Thanks for your valuable advice and feedback.
Is it advisable to perchese corona remedies ipo as per it’s gmp, for short period.
Hi RM Bhavsar,
You can buy it for short term, as the company is very strong as per the financials, and the industry also booming in coming years. So you can go for short and long both.
If Corona Remedies IPO allotted, than when I sell it?
Hi Satish,
The Corona Remedies IPO will be a good asset to have in your portfolio. Keep your stop loss of 10% everytime it goes up. You will never loose in stock market.